Second Amendment to Employment Agreement between MYMD Pharmaceuticals, Inc. and Chris Chapman, MD

Summary

MYMD Pharmaceuticals, Inc. and Chris Chapman, MD have amended their original employment agreement, initially signed on November 1, 2020 and first amended on December 18, 2020. This second amendment updates the stock option vesting schedule, specifying that 250,000 stock options will vest immediately on the effective date of the agreement. All other terms of the original agreement remain unchanged.

EX-10.15 10 ex10-15.htm

Exhibit 10.15

Second Amendment to Employment Agreement

WHEREAS, MYMD Pharmaceuticals. Inc (the “Company”) and Chris Chapman, MD (“Employee”) (collectively “the Parties”) entered into an Employment Agreement dated November 1, 2020 and first amended on December 18, 2020 (“Agreement”); and

WHEREAS, for good and valuable consideration the Parties hereby amend the Agreement as follows:

Exhibit “C” is replaced with Exhibit “C” appended hereto.

	MYMD Pharmaceuticals, Inc.

	/s/ James A. McNulty
	By: James A. McNulty, CEO

	Date: 1/8/21

	/s/ Chris Chapman, M.D.
	Chris Chapman, MD

Date: 1/8/21

EXHIBIT “C”

Stock Option Vesting Schedule (only vested stock options may be exercised)

Set forth below is the schedule pursuant to which the Employee Stock Options granted to Employee on the Effective Date of this Agreement shall vest and become exercisable:

Two Hundred Fifty Thousand (250,000) Stock Options shall vest on the Effective Date of this Employment Agreement.